Kolaja Carey OConnor

Other

US·SEC (Form 4)

Revance Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the full record of transactions filed by Kolaja Carey OConnor. Director active across 1 companies, notably Revance Therapeutics, Inc.. Aggregated, 3 disclosures have been logged. The latest transaction was filed on 4 May 2022 — Attribution. Regulator: SEC (Form 4). All data is free.

Declarations3 total

Executives◆GrantRRevance Therapeutics, Inc.11SEC

K

Kolaja Carey OConnorDirector

06,059 shares0

Common Stock

SEC:0001479290-22-000062:0·4 May 2022

SEC ↗

Executives◆GrantRRevance Therapeutics, Inc.9SEC

K

Kolaja Carey OConnorDirector

0674 shares0